Plasma Dabrafenib and Trametinib Concentrations in Advanced BRAFV600-Mutant Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Monitoring of Plasma Concentrations of Dabrafenib and Trametinib in Advanced BRAFV600mut Melanoma Patients
Ann Dermatol Venereol 2021 Jun 25;[EPub Ahead of Print], M Raynal, JC Alvarez, P Saiag, A Beauchet, C Funck-Brentano, E Funck-BrentanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.